In glioblastoma and breast cancer, high expression of SERPINA3 is closely related to cancer cell proliferation, invasion, migration, and epithelial-mesenchymal transition, and thus leads to poor prognosis and tumor recurrence (Nimbalkar et al., 2021; Zhang et al., 2021). Here, SERPINA3 is linked to breast carcinoma.